TrialPanorama/TrialPanorama-database huggingface dataset:
Study NCT00446563 — Surrogate Endpoint (SUR): Blood pressure
Study NCT04229121 — Monitoring Biomarker (MOI): Circulating tumor DNA
Study NCT01079962 — Surrogate Endpoint (SUR): Blood pressure
Study NCT00755690 — Pharmacodynamic Biomarker (PDY): Serum phosphate
Study NCT00755690 — Surrogate Endpoint (SUR): Serum calcium
Study NCT01245101 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study NCT01339156 — Surrogate Endpoint (SUR): Blood pressure
Study NCT01374971 — Predictive Biomarker (PRD): Forkhead box protein P3
Genes: FOXP3; IPEX; JM2
Study NCT04249830 — Predictive Biomarker (PRD): B-lymphocyte surface antigen B4
Genes: CD19
Study NCT01507051 — Pharmacodynamic Biomarker (PDY): Blood coagulation
Study NCT03276247 — Predictive Biomarker (PRD): HFE mRNA
Genes: HFE; HLAH
Study NCT03513822 — Predictive Biomarker (PRD): Indoleamine 2,3-dioxygenase 1
Genes: IDO1; IDO; INDO
Study NCT02447419 — Monitoring Biomarker (MOI): Epidermal growth factor
Genes: EGF
Study NCT00658762 — Predictive Biomarker (PRD): GAD1 mRNA
Genes: GAD1; GAD; GAD67
Study NCT03798743 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT03798743 — Predictive Biomarker (PRD): ALK tyrosine kinase receptor
Genes: ALK
Study NCT03798743 — Predictive Biomarker (PRD): ROS1 mRNA
Genes: ROS1; MCF3; ROS
Study NCT02436447 — Predictive Biomarker (PRD): MTTP mRNA
Genes: MTTP; MTP
Study NCT01738269 — Predictive Biomarker (PRD): WAP four-disulfide core domain protein 2
Genes: WFDC2; HE4; WAP5
Study NCT04151069 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Immunoglobulin E
Study NCT00121511 — Predictive Biomarker (PRD); Safety Biomarker (SAF): TP53
Genes: p53; LFS1
Study NCT03823924 — Surrogate Endpoint (SUR): Bone mineral density
Study NCT00532077 — Surrogate Endpoint (SUR): Serum calcium
Study NCT01218867 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY): Vascular endothelial growth factor receptor 2
Genes: KDR; FLK1; VEGFR2
Study NCT01218867 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Vascular endothelial growth factor
Study NCT03816072 — Surrogate Endpoint (SUR): Blood pressure
Study NCT03331289 — Predictive Biomarker (PRD): SLC5A2 mRNA
Genes: SLC5A2; SGLT2
Study NCT04741620 — Predictive Biomarker (PRD): TRPV1 mRNA
Genes: TRPV1; VR1
Study NCT04741620 — Predictive Biomarker (PRD): TRPA1 mRNA
Genes: TRPA1; ANKTM1
Study NCT04741620 — Predictive Biomarker (PRD): ASIC3 mRNA
Genes: ASIC3; ACCN3; SLNAC1; TNAC1
Study NCT02411903 — Predictive Biomarker (PRD): CYP3A4 mRNA
Genes: CYP3A4; CYP3A3
Study NCT02411903 — Safety Biomarker (SAF): Cytochrome P450 2C19
Genes: CYP2C19
Study NCT00147498 — Predictive Biomarker (PRD): CP mRNA
Genes: CP
Study NCT03647215 — Predictive Biomarker (PRD): BCR mRNA
Genes: BCR; BCR1; D22S11
Study NCT03647215 — Pharmacodynamic Biomarker (PDY): Tyrosine-protein kinase ABL1
Genes: ABL1; ABL; JTK7
Study NCT00392665 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT00392665 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study NCT00392665 — Monitoring Biomarker (MOI): Epidermal growth factor
Genes: EGF
Study NCT00392665 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Vascular endothelial growth factor
Study NCT00901745 — Predictive Biomarker (PRD): APLNR mRNA
Genes: APLNR; AGTRL1; APJ
Study NCT02511847 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT02511847 — Predictive Biomarker (PRD); Safety Biomarker (SAF): TP53
Genes: p53; LFS1
Study NCT02511847 — Monitoring Biomarker (MOI): Epidermal growth factor
Genes: EGF
Study NCT03444844 — Predictive Biomarker (PRD): BCR mRNA
Genes: BCR; BCR1; D22S11
Study NCT04215822 — Predictive Biomarker (PRD): EZH2 mRNA
Genes: EZH2; KMT6
Study NCT00095108 — Predictive Biomarker (PRD): IL21
Genes: Za11; IL-21
Study NCT02424123 — Predictive Biomarker (PRD): S100B mRNA
Genes: S100B
Study NCT02404701 — Surrogate Endpoint (SUR): Urinary oxalate
Study NCT04361903 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study NCT02294786 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT02294786 — Monitoring Biomarker (MOI): Epidermal growth factor
Genes: EGF
Study NCT01938781 — Predictive Biomarker (PRD): AFP mRNA
Genes: AFP; HPAFP
Study NCT00704821 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study NCT00704821 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Vascular endothelial growth factor
Study NCT01638520 — Safety Biomarker (SAF): IL4
Genes: BSF1; IL-4; BCGF1; BCGF-1; MGC79402
Study NCT00100620 — Surrogate Endpoint (SUR): Bone mineral density
Study NCT03675737 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT03675737 — Monitoring Biomarker (MOI): Epidermal growth factor
Genes: EGF
Study NCT04206358 — Safety Biomarker (SAF): Granulocyte-macrophage colony-stimulating factor
Genes: CSF2; GMCSF
Study NCT04206358 — Safety Biomarker (SAF): PDCD1
Genes: CD279; PD1; hSLE1; PD-1
Study NCT02474667 — Predictive Biomarker (PRD): ANG mRNA
Genes: ANG; RNASE5
Study NCT01224535 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT03165994 — Predictive Biomarker (PRD): CD40 mRNA
Genes: CD40; TNFRSF5
Study NCT04691895 — Pharmacodynamic Biomarker (PDY): Angiotensin-converting enzyme
Genes: ACE; DCP; DCP1
Study NCT04691895 — Predictive Biomarker (PRD): ACE2 mRNA
Genes: ACE2; UNQ868/PRO1885
Study NCT03600467 — Predictive Biomarker (PRD): AR mRNA
Genes: AR; DHTR; NR3C4
Study NCT02554032 — Pharmacodynamic Biomarker (PDY): Angiotensin-converting enzyme
Genes: ACE; DCP; DCP1
Study NCT00814034 — Pharmacodynamic Biomarker (PDY): Blood coagulation
Study NCT01819545 — Pharmacodynamic Biomarker (PDY): Beta-secretase 1
Genes: BACE1; BACE; KIAA1149
Study NCT06354946 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT01773135 — Predictive Biomarker (PRD): POMC
Genes: MSH; POC; CLIP; ACTH; NPP; LPH
Study NCT03612180 — Safety Biomarker (SAF): Cytochrome P450 2D6
Genes: CYP2D6; CYP2DL1
Study NCT03612180 — Surrogate Endpoint (SUR): Blood pressure
Study NCT02440763 — Predictive Biomarker (PRD): ATXN1 mRNA
Genes: ATXN1; ATX1; SCA1
Study NCT02440763 — Pharmacodynamic Biomarker (PDY): Ataxin-2
Genes: ATXN2; ATX2; SCA2; TNRC13
Study NCT02440763 — Pharmacodynamic Biomarker (PDY): Ataxin-3
Genes: ATXN3; ATX3; MJD; MJD1; SCA3
Study NCT04366791 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study NCT05088577 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study NCT04043377 — Predictive Biomarker (PRD): SSTR2 mRNA
Genes: SSTR2
Study NCT01300429 — Predictive Biomarker (PRD): ALK tyrosine kinase receptor
Genes: ALK
Study NCT01300429 — Predictive Biomarker (PRD): EML4 mRNA
Genes: EML4; C2orf2; EMAPL4
Study NCT01336062 — Predictive Biomarker (PRD): Thymidylate synthase 
Genes: TYMS; TS; OK/SW-cl.29
Study NCT00968838 — Predictive Biomarker (PRD); Safety Biomarker (SAF): White blood cell
Study NCT03755947 — Pharmacodynamic Biomarker (PDY): Tyrosine-protein kinase BTK
Genes: BTK; AGMX1; ATK; BPK
Study NCT01686477 — Surrogate Endpoint (SUR): Blood pressure
Study NCT01460732 — Surrogate Endpoint (SUR): Blood pressure
Study NCT00007722 — Predictive Biomarker (PRD): IGFALS mRNA
Genes: IGFALS; ALS
Study NCT00665470 — Predictive Biomarker (PRD); Safety Biomarker (SAF): White blood cell
Study NCT00665470 — Safety Biomarker (SAF): Interleukin 2
Genes: IL2
Study NCT00665470 — Predictive Biomarker (PRD); Safety Biomarker (SAF): HLA-A
Study NCT00541788 — Predictive Biomarker (PRD): GNRH1 mRNA
Genes: GNRH1; GNRH; GRH; LHRH
Study NCT00541788 — Predictive Biomarker (PRD): SHBG mRNA
Genes: SHBG
Study NCT00842634 — Predictive Biomarker (PRD): CCR5 mRNA
Genes: CCR5; CMKBR5
Study NCT00842634 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study NCT02197780 — Predictive Biomarker (PRD): S100A12 mRNA
Genes: S100A12
Study NCT03911258 — Predictive Biomarker (PRD): CFTR mRNA
Genes: CFTR; ABCC7
Study NCT03851263 — Predictive Biomarker (PRD): PCSK9 mRNA
Genes: PCSK9; NARC1; PSEC0052
Study NCT04122053 — Predictive Biomarker (PRD): CYP1A2 mRNA
Genes: CYP1A2
Study NCT01072890 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Vascular endothelial growth factor
Study NCT00815230 — Safety Biomarker (SAF): Reactive oxygen species
Study NCT03071666 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Monitoring Biomarker (MOI): Vitamin B12
Study NCT04877210 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study NCT00633256 — Surrogate Endpoint (SUR): Blood pressure
Study NCT01442740 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05710562 — Predictive Biomarker (PRD): TTR mRNA
Genes: TTR; PALB
Study NCT03157193 — Safety Biomarker (SAF): Hyaluronic acid
Study NCT04645914 — Surrogate Endpoint (SUR): Blood pressure
Study NCT04499963 — Predictive Biomarker (PRD): IGFALS mRNA
Genes: IGFALS; ALS
Study NCT01783561 — Surrogate Endpoint (SUR): Blood pressure
Study NCT01352091 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study NCT01352091 — Predictive Biomarker (PRD): Estrogen receptor
Genes: ESR1; ESR; NR3A1
Study NCT01352091 — Predictive Biomarker (PRD): Hormone receptor
Study NCT04203147 — Surrogate Endpoint (SUR): Blood pressure
Study NCT00200187 — Surrogate Endpoint (SUR): Blood pressure
Study NCT03443115 — Pharmacodynamic Biomarker (PDY): Angiotensin-converting enzyme
Genes: ACE; DCP; DCP1
Study NCT02354560 — Predictive Biomarker (PRD): APC mRNA
Genes: APC; DP2.5
Study NCT00202722 — Surrogate Endpoint (SUR): Blood pressure
Study NCT03616730 — Surrogate Endpoint (SUR): Blood pressure
Study NCT04006522 — Safety Biomarker (SAF): PDCD1
Genes: CD279; PD1; hSLE1; PD-1
Study NCT04006522 — Predictive Biomarker (PRD): Programmed cell death 1 ligand 1
Genes: CD274; B7H1; PDCD1L1; PDCD1LG1; PDL1
Study NCT02935517 — Predictive Biomarker (PRD): CNGA3 mRNA
Genes: CNGA3; CNCG3
Study NCT02177422 — Surrogate Endpoint (SUR): Blood pressure
Study NCT01674491 — Surrogate Endpoint (SUR): Blood pressure
Study NCT01067183 — Surrogate Endpoint (SUR): Blood pressure
Study NCT00697983 — Surrogate Endpoint (SUR): Bone mineral density
Study NCT01845298 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study NCT01720147 — Predictive Biomarker (PRD): BMF mRNA
Genes: BMF
Study NCT03760939 — Predictive Biomarker (PRD): ERAS mRNA
Genes: ERAS; HRAS2; HRASP
Study NCT01658774 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT04012320 — Surrogate Endpoint (SUR): Bone mineral density
Study NCT03337347 — Monitoring Biomarker (MOI): Carcinoembryonic antigen CEA
Genes: CEACAM5; CEA
Study NCT01300676 — Surrogate Endpoint (SUR): Bone mineral density
Study NCT01154036 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study NCT00882999 — Predictive Biomarker (PRD): TNFSF13B mRNA
Genes: TNFSF13B; BAFF; BLYS; TALL1; TNFSF20; ZTNF4; UNQ401/PRO738
Study NCT03538327 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT03483324 — Predictive Biomarker (PRD): CD34 mRNA
Genes: CD34
Study NCT04358874 — Surrogate Endpoint (SUR): Blood pressure
Study NCT01364493 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT00593463 — Surrogate Endpoint (SUR): Blood pressure
Study NCT04371133 — Safety Biomarker (SAF): Netrin-1
Genes: NTN1; NTN1L
Study NCT00983619 — Predictive Biomarker (PRD): B-lymphocyte surface antigen B4
Genes: CD19
Study NCT04387890 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study NCT04519749 — Predictive Biomarker (PRD): AGA mRNA
Genes: AGA
Study NCT02493283 — Predictive Biomarker (PRD): CYP2C9 mRNA
Genes: CYP2C9; CYP2C10
Study NCT01959568 — Predictive Biomarker (PRD): PVR mRNA
Genes: PVR; PVS
Study NCT01048281 — Predictive Biomarker (PRD); Safety Biomarker (SAF): TP53
Genes: p53; LFS1
Study NCT01048281 — Predictive Biomarker (PRD): NR1H2 mRNA
Genes: NR1H2; LXRB; NER; UNR
Study NCT02388971 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY): CCR2 mRNA
Genes: CCR2; CMKBR2
Study NCT01646554 — Predictive Biomarker (PRD): KRAS mRNA
Genes: KRAS; KRAS2; RASK2
Study NCT04036539 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT03507491 — Predictive Biomarker (PRD): SPARC mRNA
Genes: SPARC; ON
Study NCT02471820 — Predictive Biomarker (PRD): RRAD mRNA
Genes: RRAD; RAD
Study NCT00930189 — Predictive Biomarker (PRD): AMD1 mRNA
Genes: AMD1; AMD
Study NCT04561063 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study NCT04530656 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study NCT04530656 — Surrogate Endpoint (SUR): Neutralizing antibody
Study NCT02765295 — Safety Biomarker (SAF): Reactive oxygen species
Study NCT03047343 — Surrogate Endpoint (SUR): Blood pressure
Study NCT00896454 — Surrogate Endpoint (SUR): Serum calcium
Study NCT03927872 — Predictive Biomarker (PRD): MB mRNA
Genes: MB
Study NCT03927872 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT03927872 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): D-dimer
Study NCT02674880 — Safety Biomarker (SAF): Hyaluronic acid
Study NCT04758806 — Predictive Biomarker (PRD): CS mRNA
Genes: CS
Study NCT00064116 — Predictive Biomarker (PRD): Leukocyte surface antigen Leu-16
Genes: MS4A1; CD20
Study NCT00064129 — Safety Biomarker (SAF): Granulocyte-macrophage colony-stimulating factor
Genes: CSF2; GMCSF
Study NCT01370369 — Surrogate Endpoint (SUR): Serum testosterone
Study NCT01838941 — Predictive Biomarker (PRD): PEX1 mRNA
Genes: PEX1
Study NCT02979522 — Predictive Biomarker (PRD): Lymphocyte activation antigen CD30
Genes: TNFRSF8; CD30; D1S166E
Study NCT00165685 — Predictive Biomarker (PRD): TG mRNA
Genes: TG
Study NCT00308152 — Surrogate Endpoint (SUR): Blood pressure
Study NCT02950805 — Predictive Biomarker (PRD): MCC mRNA
Genes: MCC
Study NCT01579578 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT01155453 — Predictive Biomarker (PRD); Safety Biomarker (SAF): PIK3CA
Genes: PI3K
Study NCT01155453 — Predictive Biomarker (PRD): RAF1 mRNA
Genes: RAF1; RAF
Study NCT03292510 — Surrogate Endpoint (SUR): Blood pressure
Study NCT00401817 — Predictive Biomarker (PRD): DDIT3 mRNA
Genes: DDIT3; CHOP; CHOP10; GADD153
Study NCT03018106 — Predictive Biomarker (PRD): Estrogen receptor
Genes: ESR1; ESR; NR3A1
Study NCT02532439 — Surrogate Endpoint (SUR): Bone mineral density
Study NCT03913559 — Predictive Biomarker (PRD): CD22 mRNA
Genes: CD22; SIGLEC2
Study NCT01552317 — Surrogate Endpoint (SUR): Blood pressure
Study NCT03070119 — Pharmacodynamic Biomarker (PDY): Superoxide dismutase Cu-Zn
Genes: SOD1
Study NCT05956925 — Surrogate Endpoint (SUR): Blood pressure
Study NCT02785887 — Predictive Biomarker (PRD): CGA mRNA
Genes: CGA
Study NCT03899077 — Predictive Biomarker (PRD): GNRH1 mRNA
Genes: GNRH1; GNRH; GRH; LHRH
Study NCT03612440 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT02753231 — Surrogate Endpoint (SUR): Blood pressure
Study NCT00123734 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): D-dimer
Study NCT04402151 — Predictive Biomarker (PRD): Glutamate carboxypeptidase II
Genes: FOLH1; FOLH; NAALAD1; PSM; PSMA; GIG27
Study NCT02828488 — Predictive Biomarker (PRD): ABCD2 mRNA
Genes: ABCD2; ALD1; ALDL1; ALDR; ALDRP
Study NCT02062489 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT02365012 — Surrogate Endpoint (SUR): Blood pressure
Study NCT04298918 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT04298918 — Monitoring Biomarker (MOI): Epidermal growth factor
Genes: EGF
Study NCT00613522 — Surrogate Endpoint (SUR): Blood pressure
Study NCT04383574 — Surrogate Endpoint (SUR): Neutralizing antibody
Study NCT03593512 — Surrogate Endpoint (SUR): Blood pressure
Study NCT00520988 — Surrogate Endpoint (SUR): Blood pressure
Study NCT00361751 — Predictive Biomarker (PRD): TG mRNA
Genes: TG
Study NCT00361751 — Predictive Biomarker (PRD): PPARA mRNA
Genes: PPARA; NR1C1; PPAR
Study NCT00361751 — Predictive Biomarker (PRD); Safety Biomarker (SAF): PIK3CA
Genes: PI3K
Study NCT01096433 — Surrogate Endpoint (SUR): Blood pressure
Study NCT01564238 — Surrogate Endpoint (SUR): Blood pressure
Study NCT00292487 — Surrogate Endpoint (SUR): Serum creatinine
Study NCT04199156 — Surrogate Endpoint (SUR): Blood pressure
Study NCT03692663 — Predictive Biomarker (PRD): Glutamate carboxypeptidase II
Genes: FOLH1; FOLH; NAALAD1; PSM; PSMA; GIG27
Study NCT03547323 — Safety Biomarker (SAF): Beta-2-microglobulin
Genes: B2M; CDABP0092; HDCMA22P
Study NCT00494338 — Predictive Biomarker (PRD): NPEPPS mRNA
Genes: NPEPPS; PSA
Study NCT00001703 — Predictive Biomarker (PRD): VHL mRNA
Genes: VHL
Study NCT01410006 — Predictive Biomarker (PRD): NF1 mRNA
Genes: NF1
Study NCT00979043 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT04198363 — Predictive Biomarker (PRD); Safety Biomarker (SAF): HP mRNA
Genes: HP
Study NCT05162950 — Predictive Biomarker (PRD): CYP21A2 mRNA
Genes: CYP21A2; CYP21; CYP21B
Study NCT01314391 — Predictive Biomarker (PRD): WT1 mRNA
Genes: WT1
Study NCT04491721 — Predictive Biomarker (PRD): Leukocyte surface antigen Leu-16
Genes: MS4A1; CD20
Study NCT02595762 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT00430846 — Predictive Biomarker (PRD): Lymphocyte activation antigen CD30
Genes: TNFRSF8; CD30; D1S166E
Study NCT00904007 — Surrogate Endpoint (SUR): Blood pressure
Study NCT03734718 — Pharmacodynamic Biomarker (PDY): Gastric inhibitory polypeptide
Genes: GIP
Study NCT02443831 — Predictive Biomarker (PRD): B-lymphocyte surface antigen B4
Genes: CD19
Study NCT02443831 — Predictive Biomarker (PRD): CD22 mRNA
Genes: CD22; SIGLEC2
Study NCT04415892 — Pharmacodynamic Biomarker (PDY): Dermal blood flow
Study NCT02914990 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT02914990 — Monitoring Biomarker (MOI): Epidermal growth factor
Genes: EGF
Study NCT02437747 — Surrogate Endpoint (SUR): Probing pocket depth
Study NCT00558545 — Predictive Biomarker (PRD): XIAP mRNA
Genes: XIAP; API3; BIRC4; IAP3
Study NCT02635061 — Predictive Biomarker (PRD): HDAC6 mRNA
Genes: HDAC6; KIAA0901; JM21
Study NCT02860533 — Surrogate Endpoint (SUR): Blood pressure
Study NCT00271752 — Monitoring Biomarker (MOI): Procalcitonin
Study NCT03994172 — Surrogate Endpoint (SUR): Bone mineral density
Study NCT03994172 — Surrogate Endpoint (SUR): Serum calcium
Study NCT01232556 — Predictive Biomarker (PRD): CD22 mRNA
Genes: CD22; SIGLEC2
Study NCT03265574 — Pharmacodynamic Biomarker (PDY): Angiotensin-converting enzyme
Genes: ACE; DCP; DCP1
Study NCT00252967 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT05986435 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study NCT00848211 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study NCT00959361 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study NCT00217100 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Monitoring Biomarker (MOI): Vitamin B12
Study NCT05217472 — Predictive Biomarker (PRD): CD40 mRNA
Genes: CD40; TNFRSF5
Study NCT00169741 — Predictive Biomarker (PRD): PAH mRNA
Genes: PAH
Study NCT00001742 — Surrogate Endpoint (SUR): Blood pressure
Study NCT00313794 — Safety Biomarker (SAF): Cytotoxic T-lymphocyte protein 4
Genes: CTLA4; CD152
Study NCT00219154 — Surrogate Endpoint (SUR): Blood pressure
Study NCT01663233 — Surrogate Endpoint (SUR): Blood pressure
Study NCT01219543 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT01219543 — Predictive Biomarker (PRD): ROS1
Genes: MCF3; ROS; c-ros-1
Study NCT01219543 — Predictive Biomarker (PRD): JAK2 mRNA
Genes: JAK2
Study NCT02069080 — Predictive Biomarker (PRD): CXCR4 mRNA
Genes: CXCR4
Study NCT01250080 — Predictive Biomarker (PRD): TLR2 mRNA
Genes: TLR2; TIL4
Study NCT01250080 — Predictive Biomarker (PRD): TLR4 mRNA
Genes: TLR4
Study NCT02890992 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study NCT00223457 — Predictive Biomarker (PRD): DMA mRNA
Genes: DMA; HLA-DMA; hCG_2001572
Study NCT01668602 — Predictive Biomarker (PRD): FES mRNA
Genes: FES; FPS
Study NCT02431000 — Predictive Biomarker (PRD): AMH mRNA
Genes: AMH; MIF
Study NCT03792646 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study NCT03792646 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT02647047 — Predictive Biomarker (PRD): ERAS mRNA
Genes: ERAS; HRAS2; HRASP
Study NCT02298075 — Predictive Biomarker (PRD): TPO mRNA
Genes: TPO
Study NCT03313323 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT02775812 — Predictive Biomarker (PRD): Programmed cell death 1 ligand 1
Genes: CD274; B7H1; PDCD1L1; PDCD1LG1; PDL1
Study NCT01319383 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study NCT02411240 — Surrogate Endpoint (SUR): Blood pressure
Study NCT02411240 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Mitochondrial DNA
Study NCT00745420 — Predictive Biomarker (PRD): SCD mRNA
Genes: SCD; FADS5; SCD1; SCDOS
Study NCT02706626 — Predictive Biomarker (PRD): ALK tyrosine kinase receptor
Genes: ALK
Study NCT03943186 — Safety Biomarker (SAF): Hyaluronic acid
Study NCT00203801 — Predictive Biomarker (PRD): DHFR mRNA
Genes: DHFR
Study NCT00203801 — Predictive Biomarker (PRD): DHPS mRNA
Genes: DHPS; DS
Study NCT00203801 — Safety Biomarker (SAF): DHFR
Genes: DHFR1
Study NCT01791985 — Predictive Biomarker (PRD): FGFR1 mRNA
Genes: FGFR1; BFGFR; CEK; FGFBR; FLG; FLT2; HBGFR
Study NCT01434953 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05806853 — Predictive Biomarker (PRD): Glutamate carboxypeptidase II
Genes: FOLH1; FOLH; NAALAD1; PSM; PSMA; GIG27
Study NCT01015300 — Predictive Biomarker (PRD): VHL mRNA
Genes: VHL
Study NCT01015300 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study NCT01015300 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Vascular endothelial growth factor
Study NCT03105947 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study NCT03105947 — Pharmacodynamic Biomarker (PDY): High density lipoprotein cholesterol
Study NCT00059020 — Monitoring Biomarker (MOI): Epidermal growth factor
Genes: EGF